Chronic News and Research

RSS

Nighttime intensivists not associated with reduced mortality

Nighttime intensivist physician staffing in intensive care units (ICUs) with a low-intensity daytime staffing model is associated with reduced mortality, according to a new study published in the New England Journal of Medicine and presented at the American Thoracic Society International Conference in San Francisco.

21 May 2012

New trial on home oxygen therapy for patients with chronic heart failure

Researchers at the University of Hull, in the UK, have just launched a major new trial investigating the effects of home oxygen therapy in patients with chronic heart failure (CHF).

21 May 2012

Tuberculosis independently predicts death from lung cancer in the elderly

Tuberculosis independently predicts death from lung cancer in the elderly, according to a new study from researchers in Hong Kong.

21 May 2012

Regenerative medicine researchers explore innovative ways to treat childhood conditions

About 3 percent of the babies born in the United States have a birth defect. Children without a birth defect are also susceptible to injury or disease. At The University of Texas Health Science Center at Houston (UTHealth), regenerative medicine researchers are exploring innovative ways to treat these conditions.

21 May 2012

Exposure to parental smoking increases risk of respiratory symptoms in children

For more than three decades, researchers have warned of the potential health risks associated with exposure to environmental tobacco smoke (ETS), especially among children whose parents smoke. Now a new study conducted by researchers from the University of Arizona reports that those health risks persist well beyond childhood, independent of whether or not those individuals end up becoming smokers later in life.

21 May 2012

Specific risk factors linked with exacerbation-prone phenotype of severe asthma

A number of specific risk factors are associated with an exacerbation-prone phenotype of severe asthma, according to a new study from researchers in Sweden.

21 May 2012

Osteopenia/osteoporosis more prevalent among male patients with pulmonary disease

There is a very high prevalence of osteopenia/osteoporosis among male patients with pulmonary disease, according to a new study from researchers in California.

21 May 2012

Study uncovers mechanism by which Notch pathway could contribute to RA

A new study led by researchers at Hospital for Special Surgery identifies the mechanism by which a cell signaling pathway contributes to the development of rheumatoid arthritis (RA). In addition, the study provides evidence that drugs under development for diseases such as cancer could potentially be used to treat RA.

21 May 2012

POZEN presents data from PA32540 Phase 1 gastric acid reduction study at DDW 2012

POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, presented data today from a Phase 1 study that found that the investigational compound, PA32540, provides faster protection compared with delayed-release, enteric-coated omeprazole (40 mg), as measured by mean time to gastric pH.

21 May 2012

Clinical data from Boston Scientific endoscopy studies to be presented at DDW

Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week (DDW), May 19 – 22 in San Diego.

19 May 2012

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Purdue Pharma L.P. will present an analysis of data from completed clinical trials for Butrans® (buprenorphine) Transdermal System CIII at the American Pain Society's (APS) 31st Annual Scientific Meeting.

19 May 2012

Data from Almirall, Forest Labs’ aclidinium studies on COPD to be presented at ATS conference

Forest Laboratories, Inc. and Almirall, S.A. today announced that they will present aclidinium-related data in 1 poster discussion session and 3 poster presentations at the American Thoracic Society (ATS) International Conference scheduled May 18 - 23 in San Francisco, CA.

19 May 2012

Research roundup: Electronic health records don't seem to improve diabetes care; Beefing up adult vaccination rates

Federal officials and health policy experts believe that electronic health records (EHRs) will improve patient care. Researchers measured adherence to diabetes care guidelines as well as patient outcomes over three years at 16 practices using EHRs and 26 practices using paper records. Practices with EHRs did not show signs of better care and providers using them "have not made the necessary changes to both work processes and ways of thinking about care that would lead to improvements in chronic illness management."

19 May 2012

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

The Endocrine Society's new scientific statement published online today represents the first comprehensive evaluation of both the basic and clinical evidence related to the non-skeletal effects of vitamin D. The statement addresses current research regarding the associations of vitamin D with immune function, hypertension, stroke, skin conditions and maternal/fetal health.

19 May 2012

JAT accepts five scientific articles co-authored by UCSD doctoral pharmacy students

The Millennium Research Institute (MRI), a nonprofit national research center formed in 2010, and the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego (UCSD) announced today five scientific articles co-authored by UCSD doctoral pharmacy students have been accepted by the Journal of Analytical Toxicology.

19 May 2012

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society (APS), honored the recipients of its sixth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

19 May 2012

Ocera’s Zysa receives CE Mark to treat IBS-d

Ocera Therapeutics Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary agents to treat gastrointestinal and liver diseases, announced today that it has received a CE Mark for Zysa (spherical carbon adsorbent, formerly AST-120) for the treatment of diarrhea predominant IBS (IBS-d), a condition affecting 10-15% of the Western world.

19 May 2012

Rare DNA variations may be responsible for differences in susceptibility to common disorders

One-letter switches in the DNA code occur much more frequently in human genomes than anticipated, but are often only found in one or a few individuals. The abundance of rare variations across the human genome is consistent with the population explosion of the past few thousand years, medical geneticists and evolutionary biologists report in the May 17 advanced online edition of Science.

19 May 2012

Study focuses on role of the brain and mind in chronic and complex pain disorders

Training the brain to reduce pain could be a promising approach for treating phantom limb pain and complex regional pain syndrome, according to an internationally known neuroscience researcher speaking today at the American Pain Society's Annual Scientific Meeting.

19 May 2012

DCI receives FDA approval for PERTZYE NDA to treat EPI

Digestive Care, Inc. (DCI), announced that the company has received U.S. Food and Drug Administration (FDA) approval of its New Drug Application (NDA) for PERTZYE, indicated for the treatment of Exocrine Pancreatic Insufficiency (EPI) due to cystic fibrosis (CF) or other conditions.

19 May 2012

Chronic News and Research

Nighttime intensivists not associated with reduced mortality

New trial on home oxygen therapy for patients with chronic heart failure

Tuberculosis independently predicts death from lung cancer in the elderly

Regenerative medicine researchers explore innovative ways to treat childhood conditions

Exposure to parental smoking increases risk of respiratory symptoms in children

Specific risk factors linked with exacerbation-prone phenotype of severe asthma

Osteopenia/osteoporosis more prevalent among male patients with pulmonary disease

Study uncovers mechanism by which Notch pathway could contribute to RA

POZEN presents data from PA32540 Phase 1 gastric acid reduction study at DDW 2012

Clinical data from Boston Scientific endoscopy studies to be presented at DDW

Data from Purdue Pharma’s Butrans clinical trials to be presented at APS annual meeting

Data from Almirall, Forest Labs’ aclidinium studies on COPD to be presented at ATS conference

Research roundup: Electronic health records don't seem to improve diabetes care; Beefing up adult vaccination rates

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders

JAT accepts five scientific articles co-authored by UCSD doctoral pharmacy students

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Ocera’s Zysa receives CE Mark to treat IBS-d

Rare DNA variations may be responsible for differences in susceptibility to common disorders

Study focuses on role of the brain and mind in chronic and complex pain disorders

DCI receives FDA approval for PERTZYE NDA to treat EPI

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News